Sprites
Mein FinanzNachrichtenJetzt AnmeldenPasswort vergessen?
Sonntag, 12.02.2012Börsentäglich über 11.000 News von 420 internationalen Medien
Erweiterte
Suche
Ad hoc-Mitteilungen

FLAMEL TECHNOLOGIES SA

4,994 Euro		-0,010
-0,20 %
WKN: 901606  ISIN: US3384881096  Ticker-Symbol: FL3  Frankfurt | 10.02.12 | 19:17 Uhr
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
FLAMEL TECHNOLOGIES SA Chart 1 Jahr
1-Woche-Intraday-Chart
FLAMEL TECHNOLOGIES SA 1-Woche-Intraday-Chart

Aktuelle News zur FLAMEL TECHNOLOGIES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
10.02. 31.8% Return Seen to Date on SmarTrend Flamel Technologies Call-SmarTrend
04.01. Flamel Technologies Shares Climbing Higher, Up 5.0%-SmarTrend
30.12. Buyers Accumulate Shares of Flamel Technologies, Up 3.8%1SmarTrend
30.12. Flamel Technologies Shares Climbing Higher, Up 3.4%1SmarTrend
02.11. Flamel Technologies Announces Profitable Third Quarter Results35Business Wire
Recent highlights include completion of new Coreg CR Supply Agreement; License and Development Agreement with Eagle Pharmaceuticals Flamel Technologies...
Mehr lesen zu:
Flamel Technologies Announces Profitable Third Quarter Results
27.10. Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call28MarketWire
LYON, FRANCE -- (Marketwire) -- 10/27/11 -- Flamel Technologies (NASDAQ: FLML) expects to release its financial results for the third quarter of 2011 on Wednesday, November 2nd, after the market close....
Mehr lesen zu:
Flamel Technologies Announces Projected Release Date of Third Quarter Results; Conference Call
18.10. Flamel Tech (FLML) Enters Coreg CR Supply Agreement with Glaxo (GSK)2StreetInsider.com
13.10. Eagle Pharmaceuticals and Flamel Technologies Announce Eagle to License Medusa Technology for Extended-Release of Tigecycline36Business Wire
Eagle Pharmaceuticals, Inc. and Flamel Technologies SA (NASDAQ: FLML) today announced that the two companies have entered into a license and development agreement for...
Mehr lesen zu:
Eagle Pharmaceuticals and Flamel Technologies Announce Eagle to License Medusa Technology for Extended-Release of Tigecycline
8 Nachrichten in den letzten 6 Monaten